/Passle/5e1358328313d50770039d23/MediaLibrary/Document/2023-09-08-09-52-59-560-AlixPartners_ShareholdervaluecreationinJapanesepharmaceuticals_final_thumbnail_1.png)
Many Japanese pharmaceutical companies have been languishing under low growth and profitability amid a ”triple whammy” business...
Ben Salcetti
Partner, AlixPartners
The world keeps getting more complex. Disruptions arise, feed off one another, cascade around the world at an accelerated pace, upend our...
/Passle/5e1358328313d50770039d23/MediaLibrary/Images/609a5490fac91e13d86c3ee2/2023-02-14-15-15-37-624-63eba599f636ea142cc2951f.jpg)
Resilient Chemical industry faces an inflection point Advanced chemistries and pure-play market participants outperformed in 2022. Demand...